XJPX4218
Market cap254mUSD
Jan 17, Last price
1,952.00JPY
1D
-0.76%
1Q
-0.31%
Jan 2017
20.49%
Name
Nichiban Co Ltd
Chart & Performance
Profile
Nichiban Co., Ltd. manufactures and sells medical products and tapes in Asia and Europe. It offers medical products, including surgical tapes, dressing tapes, first-aid bandages, hemostatic bandages, and others. The company also provides OTC products, such as anti-inflammatory patches, foot care products, waterproof films, and bandages. In addition, it offers taping tapes comprising cotton, elastic, kinesiology, strapping tapes, and others; and stationery products consisting of cellulose adhesive tapes, double sided tapes, adhesive transfer tapes, book binding tapes, and others. Further, the company provides industrial tapes for non-heavy duty packaging, carton boxes, agricultural use, vehicles, and machinery, as well as specialized tapes; and cellulose, OPP packing, kraft paper, lithographic, and crepe tapes. Nichiban Co., Ltd. was founded in 1918 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | 46,859,000 2.85% | 45,560,000 5.62% | 43,134,000 4.34% | |||||||
Cost of revenue | 44,786,000 | 45,061,000 | 41,741,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 2,073,000 | 499,000 | 1,393,000 | |||||||
NOPBT Margin | 4.42% | 1.10% | 3.23% | |||||||
Operating Taxes | 445,000 | 1,059,000 | 751,000 | |||||||
Tax Rate | 21.47% | 212.22% | 53.91% | |||||||
NOPAT | 1,628,000 | (560,000) | 642,000 | |||||||
Net income | 1,827,000 -22.94% | 2,371,000 31.07% | 1,809,000 34.00% | |||||||
Dividends | (721,000) | (622,000) | (621,000) | |||||||
Dividend yield | 1.77% | 1.56% | 1.76% | |||||||
Proceeds from repurchase of equity | (448,000) | (130,000) | ||||||||
BB yield | 1.10% | 0.33% | ||||||||
Debt | ||||||||||
Debt current | 52,000 | 81,000 | 634,000 | |||||||
Long-term debt | 2,212,000 | 2,232,000 | 2,246,000 | |||||||
Deferred revenue | (796,000) | (696,000) | ||||||||
Other long-term liabilities | 7,374,000 | 7,253,000 | 7,175,000 | |||||||
Net debt | (13,928,000) | (16,657,000) | (15,192,000) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 3,187,000 | 2,917,000 | 4,064,000 | |||||||
CAPEX | (3,626,000) | (2,895,000) | (3,126,000) | |||||||
Cash from investing activities | (3,692,000) | (1,153,000) | (2,898,000) | |||||||
Cash from financing activities | (1,225,000) | (867,000) | (691,000) | |||||||
FCF | (1,251,000) | (961,000) | (719,000) | |||||||
Balance | ||||||||||
Cash | 13,405,000 | 15,108,000 | 14,200,000 | |||||||
Long term investments | 2,787,000 | 3,862,000 | 3,872,000 | |||||||
Excess cash | 13,849,050 | 16,692,000 | 15,915,300 | |||||||
Stockholders' equity | 38,167,000 | 76,180,000 | 72,787,000 | |||||||
Invested Capital | 37,361,950 | 31,918,000 | 31,568,700 | |||||||
ROIC | 4.70% | 2.08% | ||||||||
ROCE | 4.05% | 1.01% | 2.89% | |||||||
EV | ||||||||||
Common stock shares outstanding | 20,538 | 20,682 | 20,721 | |||||||
Price | 1,984.00 3.17% | 1,923.00 13.12% | 1,700.00 -11.18% | |||||||
Market cap | 40,746,874 2.45% | 39,771,203 12.90% | 35,226,003 -11.18% | |||||||
EV | 26,818,874 | 62,676,203 | 58,033,003 | |||||||
EBITDA | 4,868,000 | 3,256,000 | 3,938,000 | |||||||
EV/EBITDA | 5.51 | 19.25 | 14.74 | |||||||
Interest | 37,000 | 37,000 | 37,000 | |||||||
Interest/NOPBT | 1.78% | 7.41% | 2.66% |